Project Grant HT94252310342
Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
- The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $300,000 Project Grant to Tulane University (The Administrators of Tulane Educational Fund) on August 15, 2025, under the Military Medical Research and Development program (CFDA 12.420). The award supports a two-year research initiative through August 14, 2027, conducted at the university's New Orleans, Louisiana facility. The project, titled "Determining Risk for Lupus Nephritis Through the Intersection of Glycobiology...
- The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
- This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
- This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.19 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. This four-year research initiative addresses toxicant-mediated pulmonary hypertension in Southwest Asia veterans, supporting advanced biomedical research designed to transform healthcare for military service members and...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...